Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Conditions: Adrenal Cortical Carcinoma; Medullary Thyroid Cancer; Thymic Neuroendocrine Carcinoma; Pancreatic Neuroendocrine Tumor Interventions: Biological: individualized mRNA neoantigen vaccine (mRNA-0523-L001) Sponsors: Shanghai Jiao Tong University School of Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Neurology | Pancreas | Pancreatic Cancer | Research | Thyroid | Thyroid Cancer | Vaccines